Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Technology Scientific & Technical Instruments

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.

TSXV:RP - Post by User

Replicel Life Sciences Inc > Andrew Schutte increases position in Replicel

<< Previous

Bullboard Posts

Next >>

Comment by MetzGERon May 30, 2022 2:25pm

113 Views

Post# 34717578

RE:RE:RE:RE:RE:RE:RE:Andrew Schutte increases position in Replicel

Of course i would sell my Shares now For 1$

But i think of Schutte give us an offer to Buy our Shares For 1$ - Why he should do this?

A) he wants to have the company For his own and is happy to own the company.

B) he knows about commercial Plans For the dermalimjector or about a Deal with Shiseido

i think B) would be more Realistix If he give us an offer For 1$/share. And in this Case his offer wouldnt be Good because Replicel would be worth 5$ in this scenario...

he is a Businessman he wouldnt Buy our shares of he is just speculating